title: Coexisting NRAS and BRAF mutations in primary familial melanomas with specific CDKN2A germline alterations.
authors.forename: Braslav
authors.initials: B
authors.lastname: Jovanovic
authors.forename: Suzanne
authors.initials: S
authors.lastname: Egyhazi
authors.forename: Malihe
authors.initials: M
authors.lastname: Eskandarpour
authors.forename: Paola
authors.initials: P
authors.lastname: Ghiorzo
authors.forename: Jane M
authors.initials: JM
authors.lastname: Palmer
authors.forename: Giovanna
authors.initials: G
authors.lastname: Bianchi Scarrà
authors.forename: Nicholas K
authors.initials: NK
authors.lastname: Hayward
authors.forename: Johan
authors.initials: J
authors.lastname: Hansson
mesh_terms: D000328:Adult; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000096:biosynthesis / Q000235:genetics*; D005192:Family Health; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D018095:Germ-Line Mutation; D006801:Humans; D008297:Male; D008545:Melanoma / Q000235:genetics*; D008875:Middle Aged; D009154:Mutation; D048493:Proto-Oncogene Proteins B-raf / Q000096:biosynthesis / Q000235:genetics*; D012878:Skin Neoplasms / Q000235:genetics*; D018631:ras Proteins / Q000096:biosynthesis / Q000235:genetics*
chemical_list: D019941:Cyclin-Dependent Kinase Inhibitor p16; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D018631:ras Proteins